Retrospective Study
Copyright ©The Author(s) 2016.
World J Gastrointest Surg. Aug 27, 2016; 8(8): 578-582
Published online Aug 27, 2016. doi: 10.4240/wjgs.v8.i8.578
Table 1 Comparison of patients’ characteristics n (%)
HALS-RP (n = 23)OPEN-RP (n = 24)P value
Age, mean42.7 ± 12.750.9 ± 18.1NS
Sex (male/female)15/818/6NS
BMI, kg/m220.8 ± 3.122.6 ± 3.30.043
ASA scoreNS
11 (4.3)1 (4.2)
222 (95.7)23 (95.8)
30 (0)0 (0)
Disease duration (month, median)132 (66-216)136 (36-256)NS
Extent of colitisNS
Pancolitis17 (73.9)16 (76.1)
Left side colitis6 (26.1)4 (19.0)
Rectal colitis0 (0)1 (4.8)
Indication for surgeryNS
Cancer/dysplasia6 (26.9)10 (41.6)
Stricture4 (17.4)2 (8.33)
Refractory to medication13 (56.5)10 (41.6)
Others0 (0)2 (4.26)
Preoperative medication
Corticosteroid (mg, median)4400 (1000-8700)950 (0-4462)NS
12 (50%)
L-CAP/G-CAP10 (434)12 (50)NS
CyA, Tarolimus3 (8.7)0 (0)NS
Biologics2 (8.7)3 (12.5)NS
Preoperative comorbidityNS
HT3 (13)4 (16.7)
DM1 (4.3)3 (12.5)
Preoperative laboratory data (average ± SD)
Leukocyte7486 ± 4785661 ± 4100.002
Hemoglobin11.8 ± 0.7413.05 ± 0.28NS
Serum albumin3.96 ± 0.114.16 ± 0.221NS
CRP1.42 ± 0.7490.29 ± 0.104NS